GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman LlcClass Action Alleges Corcept Misrepresented Relacorilant Clinical Data
Corcept Therapeutics faces securities lawsuit alleging misrepresentation of relacorilant clinical data and FDA approval prospects, while withholding known regulatory risks from investors.
CORTsecurities fraudclass action lawsuit